Glucotrack, Inc. — Form 8-K
Filed August 10, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
On August 7, 2026, Glucotrack amended its July 14, 2026 Common Stock Purchase Agreement with White Lion Capital, LLC. The amendment clarifies that Glucotrack will issue 2,505,513 commitment shares to White Lion within one business day of Registration Statement effectiveness, with shares fully earned as of the effective date regardless of other conditions. Additionally, if the Commitment Fee Price falls below the Minimum Price, Glucotrack must pay White Lion a true-up amount (up to $1,000,000 minus the product of 2,505,513 shares × Commitment Fee Price) within 120 days of the Measurement Date.
Why this rating
2.5M shares at ~$5.4M market cap represents ~46% dilution; $1M true-up obligation is 19% of company market cap. Material for micro-cap, but subordinate to registration completion risk.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.